관련 자료
At Thermo Fisher Scientific, we’re known for helping our clients solve difficult solubility and formulation development challenges. Below are just a few of our innovative solutions for small and large molecule drug development.
Quick to Clinic™: In as little as 14 weeks from receiving your API, you can have your Phase I product manufactured, labelled, packaged and delivered to the clinic. That’s up to 1 month faster than most standard timelines.
Quadrant 2™ (Predictive Modeling): Using your compound’s individualized data, Quadrant 2™ can predict the most promising solubility enhancement technology and excipient combination to meet your clinical and business objectives, at the earliest stages of development.
Quick to Care™: Our fully integrated, Quick to Care™ program is an ideal solution for new and emerging companies looking to streamline their drug development. By combining your drug substance, drug product development, and clinical manufacturing into a single solution to accelerate your discovery to proof of concept, you can save an average of 14-20 weeks of development time.
Continuous Manufacturing: With continuous manufacturing, API and excipient materials are moved non-stop through an integrated equipment train, eliminating hold times between processing steps and essentially eliminating the idea of “batch” manufacturing.
Contact Us to discuss your next drug development project.
